2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a
(Redirected from Photochlor)
| Names | |
|---|---|
| Other names
Photochlor
| |
| Identifiers | |
3D model (JSmol)
|
|
| Abbreviations | HPPH |
| ChemSpider | |
| ECHA InfoCard | Lua error in Module:Wikidata at line 880: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 880: attempt to index field 'wikibase' (a nil value).Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| E number | Lua error in Module:Wikidata at line 880: attempt to index field 'wikibase' (a nil value). |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C39H48N4O4 | |
| Molar mass | 636.837 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH) is a photosensitiser chemical that is used in photodynamic therapy.[1]
It is being developed under the brand name Photochlor.
Clinical trials
[edit | edit source]A phase I/II clinical trial started in 1997 for esophageal cancer.[2]
A phase II trial for non-small cell lung cancer is due to run from 2007 to 2011.[3]
References
[edit | edit source]- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors
- ^ Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages
External links
[edit | edit source]